Dr. Marc Steven Milsten , MD
Urology • Tulsa, OK
10901 E 48th St
Tulsa, OK 741465830
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on July 24, 2006; this date does not establish years in practice.
-
Published CMS data list 19,228 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J1071 — Injection, testosterone cypionate, 1 mg: 7,720 service units.
- J9155 — Injection, degarelix, 1 mg: 3,121 service units.
- J1952 — Leuprolide injectable, camcevi, 1 mg: 1,344 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
See all 36 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,771 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Tamsulosin Hcl — 382 prescription fills, including refills.
- Finasteride — 330 prescription fills, including refills.
- Bicalutamide — 235 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 28 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 75% of clinicians listed under Urology in Tulsa, OK (2024, 34 clinicians with data). Median for this group: 10,204. Middle half: 2,593 to 19,018.
More Medicare Part B services than 85% of clinicians listed under Urology in Oklahoma (2024, 104 clinicians with data). Median for this group: 3,116. Middle half: 991 to 12,364.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 27,467 in 2020 to 19,228 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
10901 E 48th St
Tulsa, OK 741465830
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Urologic Specialists Of Oklahoma Inc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
University Of Oklahoma College Of Medicine
1989
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
1,104 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $397,449 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $296,554 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
3,564 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$2,143,438 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $8,578.18 across 86 records.
By nature of payment (3 largest of 4)
- Consulting Fee: $3,000.00 across 1 record.
- Food and Beverage: $2,342.30 across 82 records.
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $2,000.00 across 1 record.
Reporting-company totals (3 largest of 25)
- AVYXA PHARMA, LLC: $3,423.99 across 5 records.
- Astellas Pharma Global Development: $3,000.00 across 1 record.
- Dendreon Pharmaceuticals LLC: $273.57 across 7 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
37 years (graduated 1989)
CMS Doctors and Clinicians data list 1989 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Milsten has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Milsten as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Tulsa and Oklahoma
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 75% of clinicians listed under Urology in Tulsa, OK (2024, 34 clinicians with data). Median for this group: 10,204. Middle half: 2,593 to 19,018.
More Medicare Part B services than 85% of clinicians listed under Urology in Oklahoma (2024, 104 clinicians with data). Median for this group: 3,116. Middle half: 991 to 12,364.
Medicare-allowed amount
A higher Medicare-allowed amount than 90% of clinicians listed under Urology in Tulsa, OK (2024, 34 clinicians with data). Median for this group: $210,709. Middle half: $139,879 to $292,661.
A higher Medicare-allowed amount than 80% of clinicians listed under Urology in Oklahoma (2024, 104 clinicians with data). Median for this group: $198,222. Middle half: $103,623 to $318,492.
Paid by Medicare
A higher Medicare payment amount than 90% of clinicians listed under Urology in Tulsa, OK (2024, 34 clinicians with data). Median for this group: $159,613. Middle half: $102,968 to $220,140.
A higher Medicare payment amount than 80% of clinicians listed under Urology in Oklahoma (2024, 104 clinicians with data). Median for this group: $147,333. Middle half: $76,063 to $239,733.
Medicare Part D prescriptions
More Part D prescriptions than 60% of clinicians listed under Urology in Tulsa, OK (2024, 37 clinicians with data). Median for this group: 1,349. Middle half: 1,060 to 1,873.
More Part D prescriptions than 60% of clinicians listed under Urology in Oklahoma (2024, 122 clinicians with data). Median for this group: 1,209. Middle half: 446 to 2,175.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Urology in Tulsa, OK (2024, 37 clinicians with data). Median for this group: $184,161. Middle half: $82,082 to $416,012.
A higher Part D drug cost than 95% of clinicians listed under Urology in Oklahoma (2024, 122 clinicians with data). Median for this group: $175,062. Middle half: $31,724 to $384,616.
43 active clinicians are listed under Urology with a practice address in Tulsa, OK (163 in Oklahoma).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Tulsa
18.6% of these 43 clinicians have the CMS telehealth indicator.
79.1% of these 43 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 30% from 27,467 in 2020 to 19,228 in 2024.
- 2020: 27,467
- 2021: 22,849
- 2022: 17,769
- 2023: 22,900
- 2024: 19,228
-
Medicare-allowed amount
Medicare-allowed amount decreased 19% from $487,760 in 2020 to $397,449 in 2024.
- 2020: $487,760
- 2021: $412,483
- 2022: $334,239
- 2023: $387,931
- 2024: $397,449
-
Paid by Medicare
Paid by Medicare decreased 20% from $371,190 in 2020 to $296,554 in 2024.
- 2020: $371,190
- 2021: $312,495
- 2022: $244,811
- 2023: $296,817
- 2024: $296,554
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 29% from 1,376 in 2020 to 1,771 in 2024.
- 2020: 1,376
- 2021: 1,593
- 2022: 1,767
- 2023: 1,808
- 2024: 1,771
-
30-day fills
30-day fills increased 37% from 2,604 in 2020 to 3,564 in 2024.
- 2020: 2,604
- 2021: 2,932
- 2022: 3,205
- 2023: 3,330
- 2024: 3,564
-
Part D drug cost
Part D drug cost stayed about the same: $2,255,602 in 2020 and $2,143,438 in 2024.
- 2020: $2,255,602
- 2021: $2,234,074
- 2022: $2,421,082
- 2023: $2,855,337
- 2024: $2,143,438
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 15% from $7,445.56 in 2021 to $8,578.18 in 2025.
- 2021: $7,445.56
- 2022: $2,087.69
- 2023: $2,375.68
- 2024: $2,270.86
- 2025: $8,578.18
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 86 records totaling $8,578.18.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Astellas Pharma Global Development |
Consulting Fee
Cash or cash equivalent
|
Xtandi | General | $3,000.00 |
| AVYXA PHARMA, LLC |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
— | General | $2,000.00 |
| AVYXA PHARMA, LLC |
Travel and Lodging
In-kind items and services
|
— | General | $647.52 |
| AVYXA PHARMA, LLC |
Travel and Lodging
In-kind items and services
|
— | General | $588.36 |
| Calyxo, Inc. |
Food and Beverage
In-kind items and services
|
CVAC ASPIRATION SYSTEM | General | $149.40 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $142.91 |
| Teleflex LLC |
Food and Beverage
In-kind items and services
|
BARRIGEL | General | $120.41 |
| AVYXA PHARMA, LLC |
Food and Beverage
In-kind items and services
|
— | General | $98.76 |
| AVYXA PHARMA, LLC |
Food and Beverage
In-kind items and services
|
— | General | $89.35 |
| IMMUNITYBIO, INC. |
Food and Beverage
In-kind items and services
|
ANKTIVA | General | $41.93 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $35.74 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $34.95 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $34.85 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $34.40 |
| IMMUNITYBIO, INC. |
Food and Beverage
In-kind items and services
|
ANKTIVA | General | $34.27 |
| Teleflex LLC |
Food and Beverage
In-kind items and services
|
BARRIGEL | General | $33.92 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $31.61 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $31.60 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $31.45 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
ERLEADA | General | $31.27 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
PLUVICTO | General | $30.79 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $30.47 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
PLUVICTO | General | $30.22 |
| Dendreon Pharmaceuticals LLC |
Food and Beverage
In-kind items and services
|
PROVENGE | General | $29.95 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
PLUVICTO | General | $29.92 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J1071
Injection, testosterone cypionate, 1 mg
|
7,720 | 27 | $0.10 | $0.02 |
|
J9155
Injection, degarelix, 1 mg
|
3,121 | 14 | $10.00 | $4.18 |
|
J1952
Leuprolide injectable, camcevi, 1 mg
|
1,344 | 22 | $197.00 | $53.88 |
|
99490
Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
|
1,334 | 173 | $65.00 | $58.14 |
|
81001
Manual urinalysis test with examination using microscope, automated
|
854 | 516 | $13.00 | $3.10 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
680 | 500 | $194.20 | $83.49 |
|
36415
Insertion of needle into vein for collection of blood sample
|
612 | 357 | $10.00 | $8.65 |
|
84153
Psa (prostate specific antigen) measurement, total
|
584 | 336 | $80.00 | $17.96 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
577 | 473 | $30.00 | $15.43 |
|
51798
Ultrasound measurement of bladder capacity after voiding
|
420 | 320 | $69.11 | $9.84 |
|
J1644
Injection, heparin sodium, per 1000 units
|
264 | 11 | $4.94 | $0.25 |
|
81003
Automated urinalysis test
|
225 | 210 | $12.37 | $2.19 |
|
J9217
Leuprolide acetate (for depot suspension), 7.5 mg
|
207 | 35 | $750.29 | $178.55 |
|
99439
Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month
|
180 | 85 | $80.00 | $44.10 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
168 | 152 | $296.00 | $118.20 |
|
99212
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
|
122 | 114 | $117.76 | $51.89 |
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
112 | 92 | $528.29 | $210.26 |
|
96402
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
|
110 | 60 | $99.48 | $31.22 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
103 | 102 | $285.36 | $101.87 |
|
96372
Injection of drug or substance under skin or into muscle
|
68 | 46 | $69.62 | $13.09 |
|
84403
Testosterone (hormone) level, total
|
47 | 43 | $105.00 | $25.29 |
|
76872
Ultrasound scan of pelvic region through rectum
|
44 | 40 | $170.59 | $98.13 |
|
80053
Blood test, comprehensive group of blood chemicals
|
39 | 17 | $45.00 | $10.08 |
|
51705
Simple change of bladder tube
|
36 | 31 | $249.28 | $88.20 |
|
74018
X-ray of abdomen, 1 view
|
35 | 31 | $35.60 | $18.50 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Tamsulosin Hcl | Tamsulosin Hcl | 382 | 27,950 | $4,952.47 | 116 |
| Finasteride | Finasteride | 330 | 26,350 | $5,586.78 | 88 |
| Bicalutamide | Bicalutamide | 235 | 17,502 | $6,326.73 | 73 |
| Prednisone | Prednisone | 84 | 2,671 | $420.64 | 13 |
| Abiraterone Acetate | Abiraterone Acetate | 83 | 2,670 | $287,940.20 | 12 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 63 | 3,730 | $1,034.37 | 19 |
| Trospium Chloride | Trospium Chloride | 61 | 2,923 | $2,923.03 | 23 |
| Erleada | Apalutamide | 53 | 1,800 | $775,500.92 | — |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 42 | 1,445 | $1,066.49 | 21 |
| Xtandi | Enzalutamide | 41 | 1,230 | $574,597.38 | — |
| Solifenacin Succinate | Solifenacin Succinate | 38 | 2,040 | $2,343.35 | — |
| Nubeqa | Darolutamide | 33 | 990 | $435,438.08 | — |
| Levofloxacin | Levofloxacin | 31 | 93 | $79.50 | 27 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 31 | 1,041 | $330.67 | 16 |
| Gemtesa | Vibegron | 29 | 1,350 | $18,017.47 | — |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 25 | 749 | $1,191.51 | — |
| Testosterone Cypionate | Testosterone Cypionate | 23 | 1,801 | $974.43 | 13 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 20 | 542 | $668.91 | 15 |
| Megestrol Acetate | Megestrol Acetate | 20 | 630 | $397.48 | — |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 19 | 92 | $149.84 | 14 |
| Oxybutynin Chloride | Oxybutynin Chloride | 19 | 1,410 | $351.86 | — |
| Myrbetriq | Mirabegron | 19 | 1,190 | $18,678.74 | — |
| Trospium Chloride Er | Trospium Chloride | 19 | 750 | $3,630.80 | — |
| Dutasteride | Dutasteride | 16 | 1,080 | $405.90 | — |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 15 | 69 | $91.83 | 13 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2022-07-05NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - UROLOGY
I20140619002003
AR
4880775600
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Urologic Specialists Of Oklahoma Inc
10901 E 48th St, Tulsa, OK 741465830
Phone: 9187498765
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner - Family
Advanced Practice Registered Nurse
Physician Assistant
Physician Assistant (Certified)
Physician Assistant
Physician Assistant
Urology
Doctor of Medicine (M.D.)
Urology
Doctor of Medicine (M.D.)
Urology
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated July 24, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Urology Specialists in Tulsa
- Dr. James Simon, MD
- Dr. Christopher Engles, MD
- Dr. William Cook, MD
- Dr. Thomas Rashid, MD
- Dr. Kevin Gancarczyk, MD
- Dr. Joshua Vicena, DO
Mailing Address
10901 E 48th St
Tulsa, OK 741465830
Phone: 9187498765